Evidence map›Paper›PMID 25108123›Full record

ArticleThe Journal of infection2014

Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample.

Tristan W Clark, Marie-jo Medina, Sally Batham, Martin D Curran, Surendra Parmar, Karl G Nicholson

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of infection, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06142994 (Phase 4, Efficacy and Safety of Atusin CAP in the Treatment of Subjects With Acute Bronchitis in the Primary Healthcare Setting), which is not on this map. Cited by 40 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 3 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06142994 nacompletednot on this mapstarted 2024, after this paper: background citation

Phase 4, Efficacy and Safety of Atusin CAP in the Treatment of Subjects With Acute Bronchitis in the Primary Healthcare Setting: Prospective, Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-arm Clinical Study.

TypeinterventionalSponsorNeopharm Bulgaria Ltd.Ran2024 to 2024Enrolled310ConditionsAcute BronchitisArmsAtusin CAP, Placebo
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 3 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Prevalence of respiratory viruses in stable and acute asthma: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  2. Pooled it
  3. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2017
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Tristan W ClarkDepartment of Clinical and Experimental Sciences and Respiratory Biomedical Research Unit, University of Southampton, UK; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK. Electronic address: t.w.clark@soton.ac.uk.
Marie-jo MedinaDepartment of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
Sally BathamDepartment of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
Martin D CurranPublic Health England Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge, UK.
Surendra ParmarPublic Health England Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge, UK.
Karl G NicholsonDepartment of Clinical and Experimental Sciences and Respiratory Biomedical Research Unit, University of Southampton, UK; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
University of Leicester · GBPublic Health England · GBNIHR Southampton Respiratory Biomedical Research Unit · GB

Funding

Department of Health 03/39/18
6 · The paper itself

Abstract

objectivesMany adult patients hospitalised with acute respiratory illness have viruses detected but the overall importance of viral infection compared to bacterial infection is unclear.

methodsPatients were recruited from two acute hospital sites in Leicester (UK) over 3 successive winters. Samples were taken for viral and bacterial testing.

resultsOf the 780 patients hospitalised with acute respiratory illness 345 (44%) had a respiratory virus detected. Picornaviruses were the most commonly isolated viruses (detected in 23% of all patients). Virus detection rates exceeded 50% in patients with exacerbation of asthma (58%), acute bronchitis and Influenza-like-illness (64%), and ranged from 30 to 50% in patients with an exacerbation of COPD (38%), community acquired pneumonia (36%) and congestive cardiac failure (31%). Bacterial detection was relatively frequent in patients with exacerbation of COPD and pneumonia (25% and 33% respectively) but was uncommon in all other groups. Antibiotic use was high across all clinical groups (76% overall) and only 21% of all antibiotic use occurred in patients with detectable bacteria.

conclusionsRespiratory viruses are the predominant detectable aetiological agents in most hospitalised adults with acute respiratory illness. Antibiotic usage in hospital remains excessive including in clinical conditions associated with low rates of bacterial detection. Efforts at reducing excess antibiotic use should focus on these groups as a priority. Registered International Standard Controlled Trial Number: 21521552.

Indexed as

HospitalizationAcute DiseaseAdultAgedAnti-Bacterial AgentsAsthmaBacteriaBacterial InfectionsCommunity-Acquired InfectionsDisease ProgressionDrug UtilizationFemaleHumansMalePneumoniaPulmonary Disease, Chronic ObstructiveAnti-Bacterial AgentsAcute respiratory illnessAdultsAntibioticsHospitalisationRespiratory viruses

Identifiers

PMID25108123
PMCPMC7112687
OpenAlexW2059882144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.